LncRNA FAM83H-AS1 is Associated with the Prognosis of Colorectal Carcinoma and Promotes Cell Proliferation by Targeting the Notch Signaling Pathway

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Feb 14

PMID 29434883

Citations 25

Authors

Song Lu

Wei Dong

Pei Zhao

Zhenjun Liu

Affiliations

Soon will be listed here.

Abstract

The long non-coding RNA, FAM83H antisense RNA 1 (head to head) (FAM83H-AS1), has exhibited a functional role as an oncogene in a number of different types of cancer. The aim of the present study was to reveal the dysregulation of FAM83H-AS1 in colorectal carcinoma (CRC) samples and elucidate its underlying associations with the Notch signaling pathway. The expression profiles of FAM83H-AS1 and two Notch signaling-associated molecules, Notch1 and Hes family basic-helix-loop-helix transcription factor 1 (Hes1), were measured by reverse transcription-polymerase chain reaction and western blot analysis. The Pearson χ test was employed to evaluate the associations between FAM83H-AS1 expression and clinical features. A statistically significant positive association between the expression levels of FAM83H-AS1 and those of Notch1 or Hes1 in CRC tissues was analyzed by Spearman's correlation analysis. The Kaplan-Meier method was used to compare the overall survival curves between the highly-expressed and low-expressed FAM83H-AS1 groups via a log-rank test. Specific small hairpin RNA was transfected to silence endogenous FAM83H-AS1. MTT and colony formation assays were performed to measure the growth-inhibition effect of silenced FAM83H-AS1. The levels of FAM83H-AS1, Notch1 and Hes1 were significantly increased in CRC samples and cell lines. Cell proliferation was markedly inhibited when FAM83H-AS1 was knocked down and this effect mediated by FAM83H-AS1 could be reversed by Notch1 regulators. Thus, downregulated FAM83H-AS1 exhibited an anti-proliferative role in CRC by repressing the Notch signaling pathway.

Citing Articles

Dong Y, He Y, Geng Y, Wei M, Zhou X, Lian J Cancer Cell Int. 2024; 24(1):328.

PMID: 39342235 PMC: 11439232. DOI: 10.1186/s12935-024-03503-1.

Regulation of Notch1 Signalling by Long Non-Coding RNAs in Cancers and Other Health Disorders.

Kalafut J, Czerwonka A, Czapla K, Przybyszewska-Podstawka A, Hermanowicz J, Rivero-Muller A Int J Mol Sci. 2023; 24(16).

PMID: 37628760 PMC: 10454443. DOI: 10.3390/ijms241612579.

ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis.

Feng T, Yao Y, Luo L, Zou H, Xiang G, Wei L Sci Rep. 2023; 13(1):650.

PMID: 36635290 PMC: 9837176. DOI: 10.1038/s41598-022-26643-8.

Early recruitment of PARP-dependent mA RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation.

Legartova S, Svobodova Kovarikova A, Behalova Suchankova J, Polasek-Sedlackova H, Bartova E RNA Biol. 2022; 19(1):1153-1171.

PMID: 36382943 PMC: 9673957. DOI: 10.1080/15476286.2022.2139109.

Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer.

Emam O, Wasfey E, Hamdy N Cancer Cell Int. 2022; 22(1):316.

PMID: 36229883 PMC: 9558410. DOI: 10.1186/s12935-022-02736-2.

References

Zhao L, Han T, Li Y, Sun J, Zhang S, Liu Y . The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4. FASEB J. 2016; 31(3):893-903. DOI: 10.1096/fj.201600994R. View

Peng W, Wang Z, Fan H . LncRNA NEAT1 Impacts Cell Proliferation and Apoptosis of Colorectal Cancer via Regulation of Akt Signaling. Pathol Oncol Res. 2016; 23(3):651-656. DOI: 10.1007/s12253-016-0172-4. View

Badenes M, Trindade A, Pissarra H, Lopes-da-Costa L, Duarte A . Erratum to: Delta-like 4/Notch signaling promotes Apc tumor initiation through angiogenic and non-angiogenic related mechanisms. BMC Cancer. 2017; 17(1):205. PMC: 5359941. DOI: 10.1186/s12885-017-3202-z. View

Su J, Zhang E, Han L, Yin D, Liu Z, He X . Long noncoding RNA BLACAT1 indicates a poor prognosis of colorectal cancer and affects cell proliferation by epigenetically silencing of p15. Cell Death Dis. 2017; 8(3):e2665. PMC: 5386575. DOI: 10.1038/cddis.2017.83. View

Zhang J, Feng S, Su W, Bai S, Xiao L, Wang L . Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Sci Rep. 2017; 7:42819. PMC: 5309882. DOI: 10.1038/srep42819. View

Zhang C . Long non-coding RNA FTH1P3 facilitates oral squamous cell carcinoma progression by acting as a molecular sponge of miR-224-5p to modulate fizzled 5 expression. Gene. 2017; 607:47-55. DOI: 10.1016/j.gene.2017.01.009. View

Teoh S, Das S . Notch Signalling Pathways and Their Importance in the Treatment of Cancers. Curr Drug Targets. 2017; 19(2):128-143. DOI: 10.2174/1389450118666170309143419. View

Yu H, Xue Y, Wang P, Liu X, Ma J, Zheng J . Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137. Oncogenesis. 2017; 6(3):e303. PMC: 5533948. DOI: 10.1038/oncsis.2017.7. View

Zhang C, Zhu K, Ma X . Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 2017; 396:66-75. DOI: 10.1016/j.canlet.2017.03.018. View

10.

Xiang J, Yin Q, Chen T, Zhang Y, Zhang X, Wu Z . Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 2014; 24(5):513-31. PMC: 4011346. DOI: 10.1038/cr.2014.35. View

11.

Zhou C, Wang J, Huang H, Li J, Xie Q, Liu Y . LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation. Oncogene. 2017; 36(27):3878-3889. PMC: 5525547. DOI: 10.1038/onc.2017.14. View

12.

Pei Z, Du X, Song Y, Fan L, Li F, Gao Y . Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway. Oncotarget. 2017; 8(11):18145-18153. PMC: 5392314. DOI: 10.18632/oncotarget.15210. View

13.

Wang L, Zhao Z, Feng W, Ye Z, Dai W, Zhang C . Long non-coding RNA TUG1 promotes colorectal cancer metastasis via EMT pathway. Oncotarget. 2016; 7(32):51713-51719. PMC: 5239509. DOI: 10.18632/oncotarget.10563. View

14.

Li H, Jiang X, Niu X . Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53. Med Sci Monit. 2017; 23:919-928. PMC: 5330205. DOI: 10.12659/msm.903462. View

15.

Zhang D, Sun G, Zhang H, Tian J, Li Y . Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomed Pharmacother. 2016; 85:511-516. DOI: 10.1016/j.biopha.2016.11.058. View

16.

Malakar P, Shilo A, Mogilevsky A, Stein I, Pikarsky E, Nevo Y . Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation. Cancer Res. 2016; 77(5):1155-1167. PMC: 5334181. DOI: 10.1158/0008-5472.CAN-16-1508. View

17.

Xiao W, Gao Z, Duan Y, Yuan W, Ke Y . Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma. J Exp Clin Cancer Res. 2017; 36(1):41. PMC: 5345133. DOI: 10.1186/s13046-017-0507-3. View

18.

Yang F, Lv S, Lv L, Liu Y, Dong S, Yao Z . Identification of lncRNA as a novel prognostic marker in luminal subtype breast cancer. Onco Targets Ther. 2016; 9:7039-7045. PMC: 5117955. DOI: 10.2147/OTT.S110055. View

19.

Idogawa M, Ohashi T, Sasaki Y, Nakase H, Tokino T . Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function. Int J Cancer. 2017; 140(12):2785-2791. DOI: 10.1002/ijc.30689. View

20.

Guo Q, Qian Z, Yan D, Li L, Huang L . LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling. Biomed Pharmacother. 2016; 82:589-94. DOI: 10.1016/j.biopha.2016.02.049. View